Companies Elevance Health
Elevance Health (ELV): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Elevance Health’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $21,889,039FY2023
- $20,471,976FY2024
- $22,582,314FY2025
CEO total pay was $22,582,314 in fiscal 2025, up from $20,471,976 in fiscal 2024.
FY2025: salary $1,600,000 · bonus $0 · stock awards $13,440,277 · option awards $4,199,765
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Gail Boudreaux | $1,600,000 | $0 | $13,440,277 | $4,199,765 | $2,768,000 | $0 | $574,272 | $22,582,314 |
| President and Chief Executive Officer | ||||||||
| Mark Kaye | 938,462 | 0 | 4,560,511 | 1,424,506 | 974,123 | 0 | 94,475 | 7,992,077 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Peter Haytaian | 950,000 | 0 | 3,840,306 | 1,199,710 | 986,100 | 0 | 122,372 | 7,098,488 |
| Executive Vice President and President of Carelon and CarelonRx | ||||||||
| Felicia Norwood | 950,000 | 0 | 3,840,306 | 1,199,710 | 986,100 | 0 | 97,849 | 7,073,965 |
| Executive Vice President and President of Government Health Benefits | ||||||||
| C. Morgan Kendrick | 888,462 | 0 | 3,600,237 | 1,124,813 | 922,223 | 23,417 | 102,759 | 6,661,911 |
| Executive Vice President and President of Commercial and Specialty Health Benefits | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Gail Boudreaux | $22,582,314 | $20,471,976 | $21,889,039 | ↑ +2,110,338 |
| Mark Kaye | 7,992,077 | 6,873,144 | 12,359,201 | ↑ +1,118,933 |
| Peter Haytaian | 7,098,488 | 6,345,127 | 6,978,051 | ↑ +753,361 |
| Felicia Norwood | 7,073,965 | 6,288,946 | 6,475,408 | ↑ +785,019 |
| C. Morgan Kendrick | 6,661,911 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation program, which we refer to as Total Rewards, is designed to: Attract, engage, motivate, retain and appropriately reward executives for their contributions to our business, our consumers, our associates and our shareholders. Closely align executive interests and rewards with the interests of our shareholders. Demonstrate the commitment of our Company and our Board to integrate the interests of our stakeholders (consumers, shareholders, providers and associates) with our practices and executive rewards. Drive the achievement of the Company's purpose, values and strategy. Deliver compensation that is commensurate with Company and individual performance within the context of the external market.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Willis Towers Watson (WTW) |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| C. Morgan Kendrick | PSU | 2025-03-03 | 0 | 6,258 | — | 12,516 | $2,475,039 |
| Felicia Norwood | PSU | 2025-03-03 | 0 | 6,675 | — | 13,350 | 2,639,963 |
| Gail Boudreaux | PSU | 2025-03-03 | 0 | 23,363 | — | 46,726 | 9,240,067 |
| Peter Haytaian | PSU | 2025-03-03 | 0 | 6,675 | — | 13,350 | 2,639,963 |
| Mark Kaye | PSU | 2025-03-03 | 0 | 7,927 | — | 15,854 | 3,135,129 |
| Gail Boudreaux | RSU | 2025-03-03 | — | — | 10,620 | — | 4,200,210 |
| C. Morgan Kendrick | RSU | 2025-03-03 | — | — | 2,845 | — | 1,125,198 |
| Peter Haytaian | OPTION | 2025-03-03 | — | — | 11,549 | — | 1,199,710 |
| Gail Boudreaux | OPTION | 2025-03-03 | — | — | 40,429 | — | 4,199,765 |
| Peter Haytaian | RSU | 2025-03-03 | — | — | 3,035 | — | 1,200,343 |
| Mark Kaye | OPTION | 2025-03-03 | — | — | 13,713 | — | 1,424,506 |
| Mark Kaye | RSU | 2025-03-03 | — | — | 3,604 | — | 1,425,382 |
| Felicia Norwood | RSU | 2025-03-03 | — | — | 3,035 | — | 1,200,343 |
| C. Morgan Kendrick | OPTION | 2025-03-03 | — | — | 10,828 | — | 1,124,813 |
| Felicia Norwood | OPTION | 2025-03-03 | — | — | 11,549 | — | 1,199,710 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| C. Morgan Kendrick | $1,125,198 | $2,475,039 | $1,124,813 | 52.4% |
| Felicia Norwood | 1,200,343 | 2,639,963 | 1,199,710 | 52.4% |
| Gail Boudreaux | 4,200,210 | 9,240,067 | 4,199,765 | 52.4% |
| Peter Haytaian | 1,200,343 | 2,639,963 | 1,199,710 | 52.4% |
| Mark Kaye | 1,425,382 | 3,135,129 | 1,424,506 | 52.4% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| C. Morgan Kendrick | Option | 2,596 | 469.03 | — |
| Mark Kaye | Option | 2,692 | 440.19 | — |
| Peter Haytaian | Option | 2,938 | 469.03 | — |
| Felicia Norwood | Option | 2,938 | 469.03 | — |
| C. Morgan Kendrick | Option | 5,542 | 499.11 | — |
| Peter Haytaian | Option | 6,187 | 499.11 | — |
| Felicia Norwood | Option | 6,187 | 499.11 | — |
| Mark Kaye | Option | 7,089 | 499.11 | — |
| C. Morgan Kendrick | RSU | 7,489 | — | 2,625,269 |
| Peter Haytaian | RSU | 8,268 | — | 2,898,347 |
| Felicia Norwood | RSU | 8,268 | — | 2,898,347 |
| C. Morgan Kendrick | PSU | 10,566 | — | 3,703,911 |
| Gail Boudreaux | Option | 10,794 | 469.03 | — |
| C. Morgan Kendrick | Option | 10,828 | 395.5 | — |
| Peter Haytaian | PSU | 11,483 | — | 4,025,366 |
| Felicia Norwood | PSU | 11,483 | — | 4,025,366 |
| Peter Haytaian | Option | 11,549 | 395.5 | — |
| Felicia Norwood | Option | 11,549 | 395.5 | — |
| Mark Kaye | PSU | 13,437 | — | 4,710,340 |
| Mark Kaye | Option | 13,713 | 395.5 | — |
| Mark Kaye | RSU | 14,827 | — | 5,197,605 |
| Gail Boudreaux | Option | 21,654 | 499.11 | — |
| Gail Boudreaux | RSU | 29,565 | — | 10,364,011 |
| Gail Boudreaux | PSU | 40,193 | — | 14,089,656 |
| Gail Boudreaux | Option | 40,429 | 395.5 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Ramiro G. PeruIndependent · Board Chair · Compensation and Talent · Governance | $299,750 | $224,948 | $0 | — | $28,621 | $553,319 |
| Elizabeth E. TallettIndependent · Departed during FY | 144,846 | 0 | 0 | — | 259,515 | 404,361 |
| Ryan M. SchneiderIndependent · Audit (Chair) · Governance | 155,052 | 224,948 | 0 | — | 18,621 | 398,621 |
| Bahija JallalIndependent · Compensation and Talent · Governance (Chair) | 155,052 | 224,948 | 0 | — | 18,621 | 398,621 |
| Antonio F. NeriIndependent · Compensation and Talent (Chair) · Governance | 143,925 | 224,948 | 0 | — | 18,621 | 387,495 |
| Susan D. DeVoreIndependent · Compensation and Talent · Finance (Chair) | 143,925 | 224,948 | 0 | — | 10,000 | 378,874 |
| R. Kerry ClarkIndependent · Audit · Finance · Not standing for re-election | 136,178 | 224,948 | 0 | — | 10,000 | 371,126 |
| Robert L. Dixon JrIndependent · Compensation and Talent · Finance | 125,052 | 224,948 | 0 | — | 18,621 | 368,621 |
| Deanna D. StrableIndependent · Audit · Governance | 125,052 | 224,948 | 0 | — | 10,000 | 360,000 |
| Lewis Hay IIIIndependent · Audit · Finance | 125,052 | 224,948 | 0 | — | 10,000 | 360,000 |
| Steven H. CollisIndependent · Audit · Finance | 52,147 | 175,508 | 0 | — | 10,000 | 237,655 |
| Amy W. SchulmanIndependent · Audit · Finance · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Gail K. BoudreauxEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $225,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 30,000 / 30,000 |
| Stock ownership guideline | See “Corporate Governance — Board Practices, Processes and Policies — Board Equity Compensation and Stock Ownership Guidelines” for a discussion of our directors’ stock ownership requirements. |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,606,031 |
| Equity awards (grant-date value) | $2,200,040 |
| All other compensation | $412,620 |
| Total cost of the board | $4,218,691 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Elevance Health as a peer
Companies that benchmark against ELV
14 companies name ELV as a compensation peer
The list of companies that name ELV as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Peer reciprocity
Of the companies Elevance Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Elevance Health.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Elevance Health | 2025 | Gail Boudreaux | $1,600,000 | $13,440,277 | $4,199,765 | $2,768,000 | $22,582,314 |
| — | CVS Health Corporation | — | — | — | — | — | — | not in coverage universe |
| — | Amazon.com, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | AT&T Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Cencora, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Chevron Corporation | — | — | — | — | — | — | not in coverage universe |
| — | Ford Motor Company | — | — | — | — | — | — | not in coverage universe |
| — | Morgan Stanley | — | — | — | — | — | — | not in coverage universe |
| — | PepsiCo, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Target Corporation | — | — | — | — | — | — | not in coverage universe |
| — | The Goldman Sachs Group, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Valero Energy Corporation | — | — | — | — | — | — | not in coverage universe |
| — | Verizon Communications Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Walgreens Boots Alliance, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Walmart Inc. | — | — | — | — | — | — | not in coverage universe |
| — | McKesson Corporation | — | — | — | — | — | — | not in coverage universe |
| — | The Home Depot, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Lowe's Companies, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Johnson & Johnson | — | — | — | — | — | — | not in coverage universe |
| — | The Procter & Gamble Company | — | — | — | — | — | — | not in coverage universe |
| — | Berkshire Hathaway Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Marathon Petroleum Corporation | — | — | — | — | — | — | not in coverage universe |
| — | Phillips 66 | — | — | — | — | — | — | not in coverage universe |
| — | Federal National Mortgage Association | — | — | — | — | — | — | not in coverage universe |
| — | Comcast Corporation | — | — | — | — | — | — | not in coverage universe |
| — | Alphabet Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Dell Technologies Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Federal Home Loan Mortgage Corporation | — | — | — | — | — | — | not in coverage universe |
| — | JPMorgan Chase & Co. | — | — | — | — | — | — | not in coverage universe |
| — | The Kroger Co. | — | — | — | — | — | — | not in coverage universe |
| — | Meta Platforms, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Elevance Health | not disclosed | not disclosed | not disclosed | not disclosed |
| Alphabet Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Amazon.com, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| AT&T Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Berkshire Hathaway Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Cencora, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Chevron Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Comcast Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| CVS Health Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Dell Technologies Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Federal Home Loan Mortgage Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Federal National Mortgage Association | not disclosed | not disclosed | not disclosed | not disclosed |
| Ford Motor Company | not disclosed | not disclosed | not disclosed | not disclosed |
| Johnson & Johnson | not disclosed | not disclosed | not disclosed | not disclosed |
| JPMorgan Chase & Co. | not disclosed | not disclosed | not disclosed | not disclosed |
| Lowe's Companies, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Marathon Petroleum Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| McKesson Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Meta Platforms, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Morgan Stanley | not disclosed | not disclosed | not disclosed | not disclosed |
| PepsiCo, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Phillips 66 | not disclosed | not disclosed | not disclosed | not disclosed |
| Target Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| The Goldman Sachs Group, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| The Home Depot, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| The Kroger Co. | not disclosed | not disclosed | not disclosed | not disclosed |
| The Procter & Gamble Company | not disclosed | not disclosed | not disclosed | not disclosed |
| Valero Energy Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Verizon Communications Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Walgreens Boots Alliance, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Walmart Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-13 | 172,363,616 | 7,240,619 | 199,534 | 95.97% | Passed |
| 2025 | 2025-05-14 | 173,964,580 | 15,522,459 | 238,310 | 91.81% | Passed |
| 2024 | 2024-05-15 | 179,754,212 | 15,863,613 | 656,970 | 91.89% | Passed |
| 2023 | 2023-05-10 | 187,532,307 | 11,449,434 | 665,501 | 94.25% | Passed |
| 2022 | 2022-05-18 | 187,509,042 | 15,306,362 | 744,902 | 92.45% | Passed |
| 2021 | 2021-05-26 | 190,414,081 | 13,239,807 | 296,894 | 93.5% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-13 | 95.97%a |
| 2025 | 2025-05-14 | 91.81%b |
| 2024 | 2024-05-15 | 91.89%c |
a. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of any proposal.”.
b. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of any proposal.”.
c. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of any proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 286 : 1 |
|---|---|
| CEO total compensation | $22,582,314 |
| Median employee compensation | $79,007 |
Insider trades since the proxy
Equity transactions since the proxy statement are temporarily unavailable — recheck shortly.
Sources (47 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Gail Boudreaux. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 22,582,314. View filing ↗
- Section 01, Mark Kaye. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 7,992,077. View filing ↗
- Section 01, Peter Haytaian. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 7,098,488. View filing ↗
- Section 01, Felicia Norwood. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 7,073,965. View filing ↗
- Section 01, C. Morgan Kendrick. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 6,661,911. View filing ↗
- Section 03, C. Morgan Kendrick PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Felicia Norwood PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Gail Boudreaux PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Peter Haytaian PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Kaye PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Gail Boudreaux RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, C. Morgan Kendrick RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Peter Haytaian OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Gail Boudreaux OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Peter Haytaian RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Kaye OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Kaye RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Felicia Norwood RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, C. Morgan Kendrick OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Felicia Norwood OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-03-27. Section “CEO Pay Ratio”. As printed: 286 : 1. View filing ↗
- Section 08, Ramiro G. Peru. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 553,319. View filing ↗
- Section 08, Elizabeth E. Tallett. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 404,361. View filing ↗
- Section 08, Ryan M. Schneider. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 398,621. View filing ↗
- Section 08, Bahija Jallal. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 398,621. View filing ↗
- Section 08, Antonio F. Neri. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 387,495. View filing ↗
- Section 08, Susan D. DeVore. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 378,874. View filing ↗
- Section 08, R. Kerry Clark. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 371,126. View filing ↗
- Section 08, Robert L. Dixon Jr. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 368,621. View filing ↗
- Section 08, Deanna D. Strable. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 360,000. View filing ↗
- Section 08, Lewis Hay III. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 360,000. View filing ↗
- Section 08, Steven H. Collis. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 237,655. View filing ↗
- Section 08, Amy W. Schulman. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Gail K. Boudreaux. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-13. Item 5.07 · say-on-pay result. As reported: 95.97% (votes for as printed: 172,363,616). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-14. Item 5.07 · say-on-pay result. As reported: 91.81% (votes for as printed: 173,964,580). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-15. Item 5.07 · say-on-pay result. As reported: 91.89% (votes for as printed: 179,754,212). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,606,031 + equity 2,200,040 + all other 412,620 = 4,218,691, summed across the director compensation table rows.
- Elevance Health (subject), Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health's own proxy. As printed: 22,582,314. View filing ↗
- Section 10a, Amazon.com, Inc. reciprocity. DEF 14A. Amazon.com, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, AT&T Inc. reciprocity. DEF 14A. AT&T Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Cencora, Inc. reciprocity. DEF 14A. Cencora, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Chevron Corporation reciprocity. DEF 14A. Chevron Corporation's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, JPMorgan Chase & Co. reciprocity. DEF 14A. JPMorgan Chase & Co.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Meta Platforms, Inc. reciprocity. DEF 14A. Meta Platforms, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗